Chhattisgarh Clinical Trials Reimbursement
By Department of Industries, Government of Chhattisgarh
Check your eligibility
Sign up and we'll tell you whether your startup qualifies for this grant.
Quick Answer
Pharmaceutical industries in Chhattisgarh can claim reimbursement of up to 50% of clinical trial expenses, capped at ₹1 crore per trial for a maximum of 5 trials.
- Funding amount
- Varies
- Funding type
- Subsidy
- Application deadline
- Rolling
- Location
- Chhattisgarh
About this subsidy
The Reimbursement of Clinical Trials program is a key incentive under the Chhattisgarh Industrial Development Policy 2024-30, specifically designed to bolster the pharmaceutical sector within the state. This initiative aims to alleviate the substantial financial burden associated with conducting crucial clinical trials for new drugs, therapies, and medical devices. By providing direct financial support in the form of reimbursements, the Government of Chhattisgarh encourages pharmaceutical industries to invest more significantly in research and development activities locally. This strategic move is intended to foster innovation, attract more pharmaceutical manufacturing units to the state, create high-skill employment opportunities, and ultimately contribute to Chhattisgarh's economic diversification and self-reliance in healthcare infrastructure. The program underscores the state's commitment to becoming a hub for pharmaceutical innovation and production, offering a competitive advantage to companies operating within its borders.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Sign up to view.
Subsidy providers
Benefits & Funding
What You Get
The program offers a reimbursement of up to 50% of the expenses incurred on clinical trials. Each trial can receive up to ₹1 crore, with a single unit eligible for reimbursement across a maximum of 5 clinical trials. This translates to a potential benefit of up to ₹5 crore per unit, significantly reducing the financial burden of R&D for pharmaceutical companies.
- Disbursement
- Reimbursement
- Bootstrap friendly
- Yes
Timelines & Process
Applications
Rolling basis
Selection Process
Applications for reimbursement are typically reviewed by a committee from the relevant government department (e.g., Department of Industries) to verify eligibility, authenticate clinical trial expenses, and ensure compliance with the Chhattisgarh Industrial Development Policy 2024-30. The review process involves scrutinizing submitted documents and may include site visits or audits to confirm the details of the clinical trials conducted.
Application Process
- 1
Submit Application
Submit your application with all required documents through the specified channel as per the policy.
You - 2
- 3
How to apply
Four steps from draft to disbursement — one action each.
- 1
See the questions before you start
Download every question this programme's application form asks, so you can prepare your answers offline before opening the portal.
- 2
Line up your documents
Keep every document from the checklist ready in one folder. Missing docs are the #1 reason applications get bounced.
- 3
Submit on the official portal
Use the official application link and verify all details before final submission.
- 4
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Program templates & documents
Files the program publishes for applicants — download these and apply in the prescribed format.
Frequently Asked Questions
Who is eligible for this reimbursement?
This program is specifically designed for Pharmaceutical sector industries that are actively conducting clinical trials within Chhattisgarh.
What is the maximum reimbursement amount per clinical trial?
Companies can receive reimbursement of up to ₹1 crore for the expenses incurred on each individual clinical trial.
Is there a limit on the number of clinical trials for which a unit can claim reimbursement?
Yes, a single pharmaceutical unit is eligible to claim reimbursement for a maximum of 5 distinct clinical trials under this policy.
What percentage of the total expenses incurred on clinical trials can be reimbursed?
The program offers a significant reimbursement of up to 50% of the verifiable expenses incurred on eligible clinical trials.
What is the total maximum reimbursement a single unit can receive under this scheme?
Considering the cap of ₹1 crore per trial and a maximum of 5 trials per unit, a pharmaceutical industry can potentially receive a cumulative reimbursement of up to ₹5 crore.
Does this program apply to all types of industries in Chhattisgarh?
No, this particular reimbursement scheme is highly specific and exclusively targeted at the Pharmaceutical sector industries engaged in clinical research and development.
Where can I find the detailed guidelines for this reimbursement?
The comprehensive guidelines for claiming this reimbursement are available in the official Chhattisgarh Industrial Development Policy 2024-30 document, which should be reviewed thoroughly.
